Toxic Myopathies
Overview
Authors
Affiliations
Muscle tissue is highly sensitive to drugs and toxins because ot its high metabolic activity and potential sites for disruption of energy-producing pathways. Early recognition of toxic myopathies is important, as they potentially are reversible on removal of the offending toxin, with greater likelihood of complete resolution the sooner this is achieved. Clinical features range from mild muscle pain and cramps to severe weakness with rhabdomyolysis, renal failure, and even death. The pathogenic bases can be multifactorial. This article reviews drugs responsible for common types of toxic myopathy and their clinical and histopathologic features and illustrates possible underlying cellular mechanisms.
Pasnoor M, Barohn R, Dimachkie M Neurol Clin. 2014; 32(3):647-70, viii.
PMID: 25037083 PMC: 4346323. DOI: 10.1016/j.ncl.2014.04.009.
Syphilitic myositis: a case-based review.
Yacyshyn E, Chiowchanwisawakit P, Emery D, Jhamandas J, Resch L, Taylor G Clin Rheumatol. 2011; 30(5):729-33.
PMID: 21210290 DOI: 10.1007/s10067-010-1668-z.
Wu J, Buettner C, Smithline H, Ngo L, Greenman R Muscle Nerve. 2010; 43(1):76-81.
PMID: 21171098 PMC: 3332539. DOI: 10.1002/mus.21847.
Rider L, Wu L, Mamyrova G, Targoff I, Miller F Rheumatology (Oxford). 2010; 49(12):2381-90.
PMID: 20802007 PMC: 2981509. DOI: 10.1093/rheumatology/keq277.
Anabolic androgenic steroid induced necrotising myopathy.
Hughes M, Ahmed S Rheumatol Int. 2009; 31(7):915-7.
PMID: 19859711 PMC: 7101568. DOI: 10.1007/s00296-009-1235-6.